Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3186 Target Snapshot

Beta tubulin · SINGLE PROTEIN · Leishmania donovani

84Compounds
9Assays
1Approved Drugs
33.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q25270. Use UniProt Q25270 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q25270 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta tubulin as ChEMBL target CHEMBL3186, mapped to UniProt Q25270. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta tubulin
SINGLE PROTEIN · Leishmania donovani
As of 2026-09-14
ChEMBL target ID
CHEMBL3186
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q25270
Beta-tubulin
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta tubulin is the right protein anchor across sources, using UniProt Q25270 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelBeta-tubulin
UniProt AccessionQ25270
Component TypeProtein
Sequence Length43 aa

Beta-tubulin

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta tubulin, mapped to UniProt Q25270. ChEMBL maps the protein component as Beta-tubulin. Sequence length is 43 aa.

Mapped IDQ25270
Review nameBeta tubulin
OrganismLeishmania donovani
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5033.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL159 6.0 IC50 1000.0 Approved
CHEMBL190320 5.89 IC50 1300.0 Preclinical
CHEMBL186524 5.82 IC50 1500.0 Preclinical
CHEMBL188768 5.82 IC50 1500.0 Preclinical
CHEMBL188453 5.8 IC50 1600.0 Preclinical
CHEMBL67 5.72 IC50 1900.0 Preclinical
CHEMBL191213 5.7 IC50 2000.0 Preclinical
CHEMBL189355 5.51 IC50 3100.0 Preclinical
CHEMBL361893 5.46 IC50 3500.0 Preclinical
CHEMBL190702 5.4 IC50 4000.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
8
5.5
1
6.0
0
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VINBLASTINE
CHEMBL159
Approved 1965
Assay Landscape

Assay Landscape

9
Total Assays
28
Tested Compounds
1
Assay Types
Functional — 9 assays, 28 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 9 28 5.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine